1Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan;
2Department of Inflammatory Bowel Disease Surgery, Hyogo College of Medicine, Nishinomiya, Japan;
3Department of Surgery, Fukuoka University Chikushi Hospital, Chikushino, Japan;
4Division of Surgical and Molecular Pathophysiology, Tohoku University, Graduate School of Medicine, Sendai, Japan;
5Laboratory of Gastrointestinal Reconstruction, Tohoku University, Graduate School of Biomedical Engineering, Sendai, Japan;
6Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen's Hospital, Yokohama, Japan;
7Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan;
8Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan;
9Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences Mie University Graduate School of Medicine;
10Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan;
11Department of Gastroenterological Surgery/Therapeutics for Inflammatory Bowel Diseases, Osaka University Graduate School of Medicine, Osaka, Japan;
12Department of Surgery, Nara Medical University, Kashihara, Japan;
13Internal Medicine, Sakura Medical Center, Toho University, Tokyo, Japan.
Correspondence: Keisuke Hata, MD, PhD. E-mail: [email protected].
SUPPLEMENTARY MATERIAL accompanies this paper at https://links.lww.com/AJG/A48
